AI-ENABLED PRECISION THERAPEUTICS
Advancing novel small molecule therapeutics for complex chronic diseases
Transforming Molecules to Medicines
AI-ENABLED DISCOVERY
COMPUTATIONAL CHEMISTRY
PRECISION DRUG DESIGN
TRANSLATIONAL PHARMACOLOGY
PRECISION DEUTERIUM STRATEGY
OUR PLATFORM
Transforming Molecules to Medicines
INVENT Pharmaceuticals advances novel small molecule therapeutics for cardiovascular, renal, pulmonary, and metabolic diseases with significant unmet medical need.
OUR SCIENTIFIC PLATFORM
AI-ENABLED DISCOVERY
Target identification and productive modeling
COMPUTATIONAL CHEMISTRY
In silico modeling and simulation to accelerate drug discovery.
TRANSLATIONAL PHARMACOLOGY
Structure-based design and optimization of small molecules.
PRECISION DRUG DESIGN
In vitro and in vivo pharmacology to de-risk and advance candidates.
PRECISION DEUTERIUM
Site-specific deuterium engineering optimizing pharmacologic performance.
Integrated Capabilities. Transformative therapies.
OUR PIPELINE
A diversified pipeline built on precision discovery.
Our pipeline of differentiated small molecule therapeutics addresses areas of significant unmet medical need. Each program is advancing through a disciplined science-driven development engine.
Addressing complex disease biology with precision.
Building the next generation of precision therapeutics.
info@inventpharma.com
THERAPEUTIC AREAS
Cardiovascular & Renal
Pulmonary Disease
Neurology & CNS
Oncology
Interconnected cardiometabolic disease biology.
Advancing precision therapeutics across complex chronic disease. Our deep
Metabolic Disease
Focused on neurodegenerative and neuropsychiatric disease mechanisms.
Addressing progressive fibrotic disease biology across organ systems.
Developing treatments for chronic metabolic dysfunction and related complications
Advancing therapies for severe pulmonary and cardiopulmonary disorders.
THERAPEUTIC FOCUS AREAS
CARDIOVASCULAR & RENAL
Targeting interconnected cardiometabolic and renal disease pathways.
PULMONARY DISEASE
Advancing therapies for severe pulmonary and cardiopulmonary disorders.
NEUROLOGY & CNS
Developing treatments for chronic metabolic dysfunction and related complications.
METABOLIC DISEASE
ONCOLOGY
Addressing progressive fibrotic disease biology across organ systems.
Focused on neurodegenerative and neuropsychiatric disease mechanisms.
